Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Queensland Health
Fuji
QuintilesIMS
Chinese Patent Office
Accenture
Covington
Johnson and Johnson
US Department of Justice

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 9,199,973

« Back to Dashboard

Title:Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
Abstract: A pharmaceutical formulation comprising the compound of formula ##STR00001##
Inventor(s): Carter; Malcolm Clive (Stevenage, GB), Cockerill; George Stuart (Stevenage, GB), Lackey; Karen Elizabeth (Durham, NC)
Assignee: Novartis AG (Basel, CH)
Filing Date:Nov 10, 2014
Application Number:14/536,896
Claims:1. A method of treating breast cancer by administering a pharmaceutical formulation presented in unit dose form comprising the compound of formula ##STR00055## as an active ingredient, wherein said active ingredient is present within said unit dose form in an amount from 0.5 mg to 1 g.

2. The method of claim 1, wherein the pharmaceutical formulation is administered as a single dose per day.

3. The method of claim 1, wherein the pharmaceutical formulation is administered as a number of sub-doses per day.

4. The method of claim 1, wherein said unit dose is a tablet.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Covington
Boehringer Ingelheim
US Department of Justice
Merck
McKesson
Mallinckrodt
Moodys
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.